An official website of the United States government
This repository is under review for potential modification in compliance with Administration directives.
Publication Information
PubMed ID
Public Release Type
Journal
Publication Year
2023
Affiliation
Wisconsin Reading Center, Department of Ophthalmology, University of Wisconsin School of Medicine and Public and Health, Madison.; Wisconsin Reading Center, Department of Ophthalmology, University of Wisconsin School of Medicine and Public and Health, Madison.; Department of Statistics, George Washington University, Washington, DC.; Department of Epidemiology, University of Colorado School of Public Health, Denver.; Department of Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, California.; Diabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona.; Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.; Department of Medicine, Columbia University Medical Center, New York, New York.; Division of Endocrinology & Diabetes, Department of Pediatrics, Washington University in St Louis School of Medicine, St Louis, Missouri.; Division of Epidemiology and Clinical Applications-Clinical Trials Branch, National Eye Institute - National Institutes of Health, Bethesda, Maryland.
Authors
Domalpally Amitha, Whittier Samuel A, Pan Qing, Dabelea Dana M, Darwin Christine H, Knowler William C, Lee Christine G, Luchsinger Jose A, White Neil H, Chew Emily Y
Studies
Abstract
Age-related macular degeneration (AMD) is a leading cause of blindness with no treatment available for early stages. Retrospective studies have shown an association between metformin and reduced risk of AMD.